Related Experiment Video
Updated: Dec 24, 2025
12:18
LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
6.1K
Extracellular vesicle-mediated nucleic acid transfer and reprogramming in the tumor microenvironment
Neha N Parayath1, Smrithi Padmakumar2, Mansoor M Amiji2
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
Cancer Letters
|April 15, 2020
Summary
Extracellular vesicles (EVs) are crucial for intercellular communication in cancer. Modulating their nucleic acid cargo offers a promising strategy for novel cancer therapies and targeted nucleic acid delivery systems.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Extracellular vesicles (EVs) are key mediators of intercellular communication within the tumor microenvironment (TME) and at metastatic sites.
- Nucleic acids within EVs are important cargo, influencing tumor progression and metastasis.
- EVs are emerging as potential therapeutic targets and delivery systems for cancer treatment.
Purpose of the Study:
- To discuss EV biology and methods for analyzing their nucleic acid contents.
- To emphasize the role of EV-mediated nucleic acid transfer in tumor progression and metastasis.
- To review strategies for modulating EV nucleic acid content for anti-tumoral effects and discuss EV mimics for nucleic acid delivery.
Main Methods:
- Review of current literature on EV biology and nucleic acid analysis.
- Discussion of EV-mediated nucleic acid transfer mechanisms in the TME.
- Exploration of engineering strategies for EV nucleic acid modulation and EV mimic development.
Main Results:
- EVs play a significant role in facilitating tumor progression and metastasis through nucleic acid transfer.
- Modulating EV nucleic acid content can suppress tumor growth and enhance immune activation.
- Engineered EVs and EV mimics show potential for targeted nucleic acid delivery.
Conclusions:
- EVs are critical players in cancer intercellular communication and metastasis.
- Targeting and engineering EVs, including EV mimics, represent a promising frontier in cancer therapy and nucleic acid delivery.
- Further research into EV biology and modulation strategies is essential for developing effective cancer treatments.
More Related Videos
Related Concept Videos
02:17The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
01:14Introduction to Nuclear Reprogramming
2.2K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.2K
01:24Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
01:51Mechanisms of Retrovirus-induced Cancers
6.7K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.7K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:29Somatic to iPS Cell Reprogramming
2.5K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.5K